Henry Schein | HSIC - Fremdkapital

Aktienkurs
72.29
Täglich Wechseln
-0.39 -0.54%
Monatlich
-10.28%
Jährlich
4.18%
Q1 Prognose
70.12




Fremdkapital Veränderung Datum
Agilent USD 3.05B 0 2025-12
Align Technology USD 0 0 2024-12
Bruker USD 1.85B 131.7M 2025-12
Cardinal Health USD 8.35B 633M 2025-12
Charles River Laboratories USD 2.14B 49.09M 2025-12
Cigna USD 30.95B 4.47B 2025-09
Concord Medical Services Hldg CNY 2.27B 199.98M 2023-06
Cooper Companies USD 1.88B 578.5M 2025-12
CVS Health USD 60.5B 6M 2025-12
Danaher USD 18.42B 1.58B 2025-12
Dentsply International USD 2.02B 2M 2025-12
Encompass Health USD 2.45B 53.3M 2025-12
Henry Schein USD 2.31B 157M 2025-12
Idexx Laboratories USD 374.84M 17K 2025-12
IQVIA Holdings USD 13.88B 1.09B 2025-12
Laboratory Of America USD 5.15B 800K 2025-12
McKesson USD 5.43B 586M 2025-12
Mettler Toledo International USD 2.09B 58.01M 2025-12
Owens Minor USD 1.8B 35.38M 2025-12
Quest Diagnostics USD 5.17B 4M 2025-12
Revvity USD 2.63B 543K 2025-12
Stryker USD 14.86B 14M 2025-12
Tenet Healthcare USD 13.09B 10M 2025-12
Thermo Fisher Scientific USD 35.85B 4B 2025-12
Universal Health Services USD 4B 53.46M 2025-12
Veradigm USD 200.4M 69K 2022-12
Waters USD 1.41B 460.24M 2025-12
Zimmer Biomet Holdings USD 6.93B 580.6M 2025-12
Zoetis USD 9.04B 1.97B 2025-12